Careers
Abcuro is a biotechnology company developing antibody-based therapies targeting highly cytotoxic T cells involved in autoimmune diseases. Its pipeline includes Ulviprubart, an investigational monoclonal antibody for inclusion body myositis and other autoimmune disorders.